Literature DB >> 17311343

Presence, quantitation and characterization of JC virus in the urine of Italian immunocompetent subjects.

Andrea Rossi1, Serena Delbue, Romina Mazziotti, Marilena Valli, Elisa Borghi, Roberta Mancuso, Maria G Calvo, Pasquale Ferrante.   

Abstract

Human polyomavirus JC (JCV) infects the worldwide population, remains latent in the kidney, and is excreted in the urine. A longitudinal study was performed in order to evaluate JCV excretion, to characterize molecularly the virus and to determine if its presence in urine is a consequence of viral reactivation or merely of epithelial squamous cell shedding. The presence of cellular sediment and the JCV genome were examined in 333 urine samples collected periodically for 3 months from 17 healthy subjects; molecular characterization, and quantitation of the virus were also undertaken. JCV DNA was detected in 40.2% of the samples, with a significant difference (P<0.001) observed between males and females. JCV shedding was independent of the presence of cellular sediment in every individual. JCV genotype 1 was the genome detected most frequently, while all of the amplified strains showed archetypal organization of the transcriptional control region (TCR). No clinical symptoms have been associated with JCV excretion and no microbial load was detected in the urine samples. The lack of correlation between JCV DNA detection and the presence of squamous cells in urine sediment indicates that viruria is regulated by the life cycle of JCV. Thus, the virus is eliminated as consequence of its reactivation. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311343     DOI: 10.1002/jmv.20829

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  21 in total

Review 1.  [Therapeutic monoclonal antibodies in clinical neurology].

Authors:  M Buttmann; H Wiendl
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

2.  Detection of human polyomavirus proteins, T-antigen and agnoprotein, in human tumor tissue arrays.

Authors:  Luis Del Valle; Kamel Khalili
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

3.  Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals.

Authors:  Serena Delbue; Emanuela Branchetti; Renzo Boldorini; Luca Vago; Pietro Zerbi; Claudia Veggiani; Sara Tremolada; Pasquale Ferrante
Journal:  J Med Virol       Date:  2008-12       Impact factor: 2.327

4.  Polyomavirus infection and its impact on renal function and long-term outcomes after lung transplantation.

Authors:  Lora D Thomas; Aaron P Milstone; Regis A Vilchez; Preeti Zanwar; Janet S Butel; J Stephen Dummer
Journal:  Transplantation       Date:  2009-08-15       Impact factor: 4.939

Review 5.  Update on PML: lessons from the HIV uninfected and new insights in pathogenesis and treatment.

Authors:  Elizabeth A Hartman; DeRen Huang
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

6.  Detection of JC virus DNA fragments but not proteins in normal brain tissue.

Authors:  Georgina Perez-Liz; Luis Del Valle; Antonio Gentilella; Sidney Croul; Kamel Khalili
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

7.  Analysis of variability of urinary excreted JC virus strains in patients infected with HIV and healthy donors.

Authors:  Danijela Karalic; Ivana Lazarevic; Ana Banko; Maja Cupic; Djordje Jevtovic; Tanja Jovanovic
Journal:  J Neurovirol       Date:  2017-12-14       Impact factor: 2.643

8.  JC virus T-Antigen DNA in gastrointestinal mucosa of immunosuppressed patients: a prospective, controlled study.

Authors:  Doron Boltin; Alex Vilkin; Zohar Levi; Ori Elkayam; Yaron Niv
Journal:  Dig Dis Sci       Date:  2009-10-03       Impact factor: 3.199

Review 9.  Potential mechanisms of the human polyomavirus JC in neural oncogenesis.

Authors:  Luis Del Valle; Martyn K White; Kamel Khalili
Journal:  J Neuropathol Exp Neurol       Date:  2008-08       Impact factor: 3.685

10.  Immunological hallmarks of JC virus replication in multiple sclerosis patients on long-term natalizumab therapy.

Authors:  Houria Hendel-Chavez; Marie-Ghislaine de Goër de Herve; Claire Giannesini; Anne-Aurélie Mazet; Caroline Papeix; Céline Louapre; Audrey Chardain; Nassima Boutarfa; Marie Théaudin; David Adams; Jacques Gasnault; Bruno Stankoff; Yassine Taoufik
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.